ok i admit following story ai surprising unless head firmly planted sand past several years said i sure glad somebody reported growing criticism big pharma failing disclose results clinical studies especially studies provide information safety effectiveness medicines taken consumers take case gsk two trials valtrex vs famvir genital herpes trials finished published last month lead researcher studies complained never given satisfactory explanation noted drugmaker responsible delay also owns medicine fared poorly i given sorts reasons said anna wald professor medicine university washington whose work comparing two drugs recently published journal sexually transmitted diseases took years receive material said moved faster gain edge smithklinebeecham funded pair comparative studies clinical trials known head head studies rarely undertaken voluntarily drugmakers due expense particular possibility results unflattering effect smithklinebeecham took gamble hopes goosing sales good reason drugs dead heat valtrex sales totaled million million prescriptions famvir rang million revenue million prescriptions according verispan market research firm team researchers led wald conducted studies smithklinebeecham never shared results even though wald said repeatedly asked data result wald said way knowing smithklinebeecham famvir compared unfavorably valtrex words smithklinebeecham lost bet glaxo smithkline merged complicating tale combined company promptly sold famvir novartis satisfy anti trust concerns glaxo spokeswoman said information available study data handled time data given wald glaxo valtrex taken lead valtrex generated million sales million prescriptions famvir rang million sales million prescriptions according verispan merger wald said began asking novartis study data receive anything early last year drug maker sent described enormous box papers said novartis personnel insisted data could located two possible interpretations said wald also consultant novartis either data got lost part transfer one company another novartis want share data cause favorable famvir might hurt sales i know novartis spokeswoman also explained famvir data stored among boxes sent glaxo talks began wald january could explain delay late wald finally received data hat tip always ecellent pharmagossip p worry drug companies share data researchers ask guy